The Northern Health Science Alliance (NHSA) has signed a memorandum of understanding (MoU) with Life Sciences Queensland (LSQ) in Australia and another MoU with SCAN Health and World Health Innovation (WIN) in Canada to open up the commonwealth life sciences economies.
MOU
These arrangements will benefit patients based in the UK, Canada and Australia as they will enable expertise and research to be shared quickly and effectively across the three countries.
“This joint working arrangement means that the life sciences industries in Australia, Canada and the UK will benefit from closer relationships,” said Dr Hakim Yadi, CEO of the Northern Health Science Alliance. “There is a real international appetite to work with the North’s health research system — demonstrated by these MOU signings and our recent MoU signing with the leading Singaporean MedTech Accelerator Zicom MedTac Pte Ltd. As a result there are now a number of Singaporean companies conducting research studies in partnership with Northern Universities and Hospitals.
“We want to best and brightest companies to come and work in the North of England — and for the best and brightest of our companies to spread their wings internationally.
“Ultimately these exchange between NHSA and Canada and Australian life sciences organisations will benefit patients in the healthcare system globally.”
Mario Pennisi, chief executive officer of Life Sciences Queensland Limited, added: “The UK presents a significant market opportunity for our members and this alliance with NHSA provides the perfect entry point to facilitate this.
“Working with our British colleagues provides us an excellent opportunity to leverage a revitalised interest in the Commonwealth.”
“Partnering with NHSA gives us tremendous reach and engagement opportunities with Northern UK healthcare systems and their respective research networks to advance health system innovation, and broker global health sector collaboration that facilitates knowledge exchange to improve performance, safety and health outcomes,” commented Dr Anne Snowdon, scientific director and CEO of SCAN Health and chair of WIN. “By working together with our combined members and partners around the world we believe we can advance knowledge and impact of supply chain maturity in health systems.”